Clinical Trials on Neoplasms, Radiation-Induced in Belgium

Total 3815 results

Jules Bordet Institute

Terminated

Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver (TRYPHON)

Liver Cirrhosis | Hepatocellular Carcinoma

Belgium
Bayer

Completed

A Local Retrospective Observational Study to Evaluate the Treatment Patterns of mCRPC Patients in Belgium Treated With Radium-223 (BELFIGO)

Prostatic Neoplasms, Castration-Resistant

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma (CELEBRIDO)

Endometrium Cancer

Belgium
European Organisation for Research and Treatment...

Completed

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Sarcoma | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Endometrial Cancer | Melanoma (Skin)

Belgium
University of Liege

Completed

Feasibility and Impact of Group Interventions on Breast Cancer Patients Well-being (GIBC)

Breast Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Age-related Changes in the Immune System and Their Impact on Elderly Breast Cancer (IMAGE)

Breast Cancer

Belgium
Jules Bordet Institute
Centre Hospitalier Universitaire de Tivoli; Hôpital de Braine-l'Alleud; Clinique... and other collaborators

Completed

Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer Patients

Breast Cancer

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery (HNSCC)

Surgery | Head and Neck Squamous Cell Carcinoma | Growth Factor

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Diffusion MRI; Predictive Value for Cervical Uterine Cancer Recurrence (s52647)

Recurrence | Uterine Cervical Cancer | Diffusion-weighted MRI

Belgium
University Hospital, Ghent
Nationaal Kankerplan

Terminated

Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers (PEARL-2)

Inoperable Early Stage Non-small Cell Lung Cancer

Belgium
University Hospital, Ghent

Completed

Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial

Bowen's Disease | Superficial Basal Cell Carcinoma

Belgium
Cliniques universitaires Saint-Luc- Université...
Centre Georges Francois Leclerc

Completed

Simultaneous Integrated Boost (SIB)- IMRT

Carcinoma, Squamous Cell

Belgium
The Belgian Society of Medical Oncology

Recruiting

The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment

Metastatic Cancer

Belgium
University Hospital, Gasthuisberg
Fondazione Policlinico Universitario Agostino Gemelli IRCCS; University Medical...

Recruiting

Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment (EUGENIE)

Endometrial Cancer

Belgium
European Lung Cancer Working Party

Completed

Bronchoscopy Assisted by Electromagnetic Navigation (EMN) in the Diagnosis of Small Pulmonary Nodules

Pulmonary Nodule Cm

Belgium
Universitair Ziekenhuis Brussel
Vrije Universiteit Brussel

Completed

Simultaneous Integrated Boost Preoperative Radiotherapy for Rectum Cancer (RectumSIB)

Rectal Cancer

Belgium
Cliniques universitaires Saint-Luc- Université...
Immutep S.A.S.

Terminated

Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides

Melanoma

Belgium
Cliniques universitaires Saint-Luc- Université...
Institut Pasteur

Unknown

Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients (THERAVAC)

Melanoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer (S53580)

Ovarian Carcinoma

Belgium
Jules Bordet Institute

Completed

177Lutetium-octreotate Treatment Prediction Using Multimodality Imaging in Refractory NETs (LUMEN)

Gastroenteropancreatic Neuroendocrine Tumors

Belgium
KU Leuven

Completed

Survival Analysis of Oral Cancer Patients

Head and Neck Cancer

Belgium
University Hospital, Ghent

Completed

Highly Accelerated Dose-Integrated Radiotherapy in 5 Fractions in Breast Cancer (HAI-5)

Breast Cancer | Radiotherapy

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy

Transitional Cell Carcinoma

Belgium
Cliniques universitaires Saint-Luc- Université...

Recruiting

Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer (AVETUXIRI)

Colorectal Neoplasms, Malignant

Belgium
Jules Bordet Institute

Recruiting

Multidisciplinary Approach to Fatigue

Breast Cancer | Germ Cell Tumor

Belgium
Cliniques universitaires Saint-Luc- Université...

Recruiting

Patient-derived Xenograft Models of Tumor From Patients With Head and Neck Cancer (UCL-Xenog)

Squamous Cell Carcinoma of the Head and Neck

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

I-Scan For Colon Polyp Detection In HNPCC

Lynch Syndrome | Hereditary Non-polyposis Colon Carcinoma | HNPCC

Belgium
University Hospital, Ghent

Completed

Double-Blind Randomized Placebo-Controlled Trial on Clinical and Biological Effects of Oral Corticosteroids or Doxycyclin in Patients With Nasal Polyposis

Nasal Polyposis

Belgium
AZ Sint-Jan AV

Recruiting

Value of Geriatric Screening to Predict Postoperative Morbidity for Head and Neck Cancer (GEROP)

Head and Neck

Belgium
University Hospital, Ghent
Jessa Hospital; University Hospital, Antwerp; AZ Sint-Jan AV; AZ Delta; General Hospital... and other collaborators

Terminated

BLood Groups as Biomarker to Optimize Odds of Response to Anti-PD-1 Drugs (BLOOD)

Melanoma | Cancer

Belgium
Jules Bordet Institute

Recruiting

Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors (LIFE)

Non Small Cell Lung Cancer

Belgium
European Hepatocellular Cancer Liver Transplant...

Completed

A Worldwide Score for Hepatocellular Cancer and Liver Transplantation (TRAIN-SCORE)

Recurrence | Liver Cancer | Dropout, Patient

Belgium
University Hospital, Ghent

Completed

A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer

Squamous Cell Carcinoma

Belgium
Universitair Ziekenhuis Brussel

Active, not recruiting

Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherparepvec (T-VEC) (myDCTV)

Melanoma

Belgium
Universitair Ziekenhuis Brussel

Recruiting

MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days (Proseven)

Prostate Cancer

Belgium
Vrije Universiteit Brussel
Jessa Hospital; Roche Diagnostics

Recruiting

Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment (DECONGEST)

Acute Heart Failure | Diuretics Drug Reactions

Belgium
Ludwig Institute for Cancer Research

Terminated

Immunization With 8 Peptides Mixed With CpG 7909 or Montanide ISA51 in Patients With Metastatic Cutaneous Melanoma

Malignant Melanoma

Belgium
Ludwig Institute for Cancer Research

Terminated

Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma

Malignant Melanoma

Belgium
Cliniques universitaires Saint-Luc- Université...

Terminated

Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma

Metastatic Melanoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib (LAT-FLOSI)

Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor

Belgium
Universiteit Antwerpen
KU Leuven

Recruiting

Reliability and Validity of Ultrasound for the Assessment of Soft Tissue Properties After Breast Cancer Treatment (SOFT-TI)

Breast Neoplasms

Belgium
University Hospital, Antwerp
Universitair Ziekenhuis Brussel; General Hospital Groeninge; AZ Nikolaas; Erasme... and other collaborators

Active, not recruiting

Retrospective Study on the Efficacy and Tolerability of Liposomal Irinotecan (NALIRI)

Metastatic Pancreatic Ductal Adenocarcinoma

Belgium
Jules Bordet Institute

Completed

A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma

Ovarian Carcinoma | Relapse

Belgium
University Hospital, Ghent

Completed

Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor

Head and Neck Tumor

Belgium
Universitaire Ziekenhuizen KU Leuven

Active, not recruiting

Metastasis-directed Therapy in Castration-refractory Prostate Cancer (MEDCARE)

Castration-resistant Prostate Cancer

Belgium
University Hospital, Ghent
Takeda

Completed

Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.

Prostate or Bladder Cancer

Belgium
Erasme University Hospital

Recruiting

Added Value of a Small Camera (Iriscope) in the Endoscopic Diagnosis of Peripheral Lung Nodules and Masses

Pulmonary Nodule, Solitary

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults (FUBEO)

Osteosarcoma | Ewing Sarcoma

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

SBRT in the Management of Solid Spinal Metastases

Spinal Metastases | Extradural Tumor

Belgium
University Hospital, Ghent
University Ghent; Kom Op Tegen Kanker

Active, not recruiting

MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer (MIDRIXNEO)

Non-small Cell Lung Cancer

Belgium

Clinical Trials on Neoplasms, Radiation-Induced in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations